Next Article in Journal / Special Issue
Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay
Previous Article in Journal / Special Issue
Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis
Open AccessArticle

High Reproducibility of ELISPOT Counts from Nine Different Laboratories

Cellular Technology Limited, Shaker Hts. 44122, OH, USA
Européen Georges Pompidou, Paris 75015, France
Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Copenhagen University Hospital, Hvidovre and Department of International Health, Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2650, Denmark
Development Translational Medicine, Biogen Idec, Cambridge 02142, MA, USA
Immuno-Virology Drug Discovery, Bristol-Myers Squibb, Wallingford 06492, CT, USA
Immuno-Sciences Biology Drug Discovery, Bristol-Myers Squibb, Princeton 08543, NJ, USA
Nottingham Trent University, Nottingham NG118NS, UK
Medizinische Hochschule Hannover 30625, Germany
Pharmasan Labs, Osceola 54020, WI, USA
Latvian Biomedical Research and Study Center, Riga LV1067, Latvia
Author to whom correspondence should be addressed.
Academic Editor: Alexander E. Kalyuzhny
Cells 2015, 4(1), 21-39;
Received: 24 October 2014 / Accepted: 26 November 2014 / Published: 9 January 2015
(This article belongs to the Special Issue ELISPOT Research)
The primary goal of immune monitoring with ELISPOT is to measure the number of T cells, specific for any antigen, accurately and reproducibly between different laboratories. In ELISPOT assays, antigen-specific T cells secrete cytokines, forming spots of different sizes on a membrane with variable background intensities. Due to the subjective nature of judging maximal and minimal spot sizes, different investigators come up with different numbers. This study aims to determine whether statistics-based, automated size-gating can harmonize the number of spot counts calculated between different laboratories. We plated PBMC at four different concentrations, 24 replicates each, in an IFN-γ ELISPOT assay with HCMV pp65 antigen. The ELISPOT plate, and an image file of the plate was counted in nine different laboratories using ImmunoSpot® Analyzers by (A) Basic Count™ relying on subjective counting parameters set by the respective investigators and (B) SmartCount™, an automated counting protocol by the ImmunoSpot® Software that uses statistics-based spot size auto-gating with spot intensity auto-thresholding. The average coefficient of variation (CV) for the mean values between independent laboratories was 26.7% when counting with Basic Count™, and 6.7% when counting with SmartCount™. Our data indicates that SmartCount™ allows harmonization of counting ELISPOT results between different laboratories and investigators. View Full-Text
Keywords: ELISPOT; Smart Count™; Log Normal distribution; harmonization ELISPOT; Smart Count™; Log Normal distribution; harmonization
Show Figures

Figure 1

MDPI and ACS Style

Sundararaman, S.; Karulin, A.Y.; Ansari, T.; BenHamouda, N.; Gottwein, J.; Laxmanan, S.; Levine, S.M.; Loffredo, J.T.; McArdle, S.; Neudoerfl, C.; Roen, D.; Silina, K.; Welch, M.; Lehmann, P.V. High Reproducibility of ELISPOT Counts from Nine Different Laboratories. Cells 2015, 4, 21-39.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop